Search

Clinical trials

The advance of highly innovative, increasingly personalized therapies in hematology requires novel clinical trial designs and more flexible, adaptive regulatory frameworks and improved data generation to support decision making both during and after clinical studies.

Read more

YoungEHA Committee

Current committee members
Mandy Lauw, The Netherlands (Chair)
Anna Kabanova, Italy (Vice Chair)
Elizabeth Macintyre, France (EHA Past President)
Regular members
Anna Avagyan, Armenia 
Nuno Borges, United Kingdom 
Katherine Bridge, United Kingdom 
Lorenzo Brunetti, Italy 
Eleni Gavriilaki, Greece 
William Grey, United Kingdom 
Ruxandra Irimia, Romania
Rafal Machowicz, Poland
Anna Maiques Diaz, Spain
Ana Filipa…

Read more

EU Parliament agrees on pharmaceutical legislation stance

On April 10, the European Parliament adopted its position on the revision of the EU pharmaceutical legislation.

Read more

Immunoglobulin shortages in the spotlight: EMA, SUPPLY and the SoHO Regulation

EMA executive director Emer Cooke welcoming participants including EHA at the Shortages Workshop, March 1

 

Shortages of immunoglobulins and the need to increase and sustain plasma supplies have moved to the center of the EU policy and regulatory stage.

Read more

Press Release: Economic burden of blood disorders in EU is €23 billion

The economic burden of blood disorders across the European Union, Iceland, Norway and Switzerland amounts to €23 billion per year.

Read more